Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Nov 22, 2024 | 25.08 | 0.00 |
PowerUp Acquisition A | PWUP | Nov 22, 2024 | 11.49 | -0.04 |
PowerUp Acquisition Unit | PWUPU | Nov 22, 2024 | 11.45 | 0.00 |
PPG Industries | PPG | Nov 22, 2024 | 122.65 | -0.02 |
PPL | PPL | Nov 22, 2024 | 34.45 | -1.15 |
PRA Group | PRAA | Nov 22, 2024 | 21.72 | +4.02 |
Prairie Operating | PROP | Nov 22, 2024 | 8.77 | +6.82 |
Praxis Precision Medicines | PRAX | Nov 22, 2024 | 74.50 | +1.97 |
Precigen | PGEN | Nov 22, 2024 | 0.90 | -0.03 |
Precipio | PRPO | Nov 22, 2024 | 5.91 | -1.51 |
Precision BioSciences | DTIL | Nov 22, 2024 | 7.26 | +11.69 |
Precision Drilling | PDS | Nov 22, 2024 | 66.38 | +0.38 |
Precision Optics | POCI | Nov 22, 2024 | 5.11 | +0.39 |
Predictive Oncology | POAI | Nov 22, 2024 | 0.72 | +4.50 |
Preferred Bank | PFBC | Nov 22, 2024 | 95.67 | +2.04 |
Preferred Portfolio Powershares | PGX | Nov 22, 2024 | 11.95 | +0.08 |
Preformed Line Products | PLPC | Nov 22, 2024 | 138.52 | +1.70 |
Prelude Therapeutics | PRLD | Nov 22, 2024 | 0.95 | -1.91 |
Premier A | PINC | Nov 22, 2024 | 22.84 | +1.87 |
Premier Financial | PFC | Nov 22, 2024 | 28.85 | +2.09 |
Premium Catering Holdings | PC | Nov 22, 2024 | 0.71 | 0.00 |
Prenetics Global A | PRE | Nov 22, 2024 | 4.42 | 0.00 |
Presidio Property Trust A | SQFT | Nov 22, 2024 | 0.57 | +17.07 |
Presidio Property Trust D Pref | SQFTP | Nov 22, 2024 | 14.50 | +0.66 |
Prestige Consumer Healthcare | PBH | Nov 22, 2024 | 84.85 | +0.84 |
Prestige Wealth | PWM | Nov 22, 2024 | 1.07 | +3.88 |
PriceSmart | PSMT | Nov 22, 2024 | 89.96 | +1.67 |
Prime Medicine | PRME | Nov 22, 2024 | 3.20 | +7.74 |
Primech Holdings | PMEC | Nov 22, 2024 | 0.76 | +1.33 |
PrimeEnergy Resources | PNRG | Nov 22, 2024 | 202.95 | -1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.